LOADING
Comparing JPMorgan Chase (JPM) and Johnson & Johnson (JNJ) across the Financials and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | JPM | JNJ |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $835.2B | $555.2B |
| P/E Ratio | 14.9 | 26.7 |
| Forward P/E | 14.5 | 20.0 |
| PEG Ratio | 1.68 | 3.01 |
| EPS | $20.88 | $8.63 |
| Revenue Growth (YoY) | 12.7% | 9.9% |
| Profit Margin | 33.9% | 21.8% |
| Return on Equity | 16.5% | 35.0% |
| Dividend Yield | 1.88% | 2.30% |
| Beta | 1.04 | 0.33 |
| 52-Week High | $334.16 | $251.71 |
| 52-Week Low | $233.88 | $142.16 |
| Volume | -- | -- |
JPMorgan Chase is the larger company by market capitalization. JPMorgan Chase trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Johnson & Johnson offers a higher dividend yield for income investors. JPMorgan Chase has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.